Your browser doesn't support javascript.
loading
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.
Babiloni, Claudio; Arakaki, Xianghong; Azami, Hamed; Bennys, Karim; Blinowska, Katarzyna; Bonanni, Laura; Bujan, Ana; Carrillo, Maria C; Cichocki, Andrzej; de Frutos-Lucas, Jaisalmer; Del Percio, Claudio; Dubois, Bruno; Edelmayer, Rebecca; Egan, Gary; Epelbaum, Stephane; Escudero, Javier; Evans, Alan; Farina, Francesca; Fargo, Keith; Fernández, Alberto; Ferri, Raffaele; Frisoni, Giovanni; Hampel, Harald; Harrington, Michael G; Jelic, Vesna; Jeong, Jaeseung; Jiang, Yang; Kaminski, Maciej; Kavcic, Voyko; Kilborn, Kerry; Kumar, Sanjeev; Lam, Alice; Lim, Lew; Lizio, Roberta; Lopez, David; Lopez, Susanna; Lucey, Brendan; Maestú, Fernando; McGeown, William J; McKeith, Ian; Moretti, Davide Vito; Nobili, Flavio; Noce, Giuseppe; Olichney, John; Onofrj, Marco; Osorio, Ricardo; Parra-Rodriguez, Mario; Rajji, Tarek; Ritter, Petra; Soricelli, Andrea.
Afiliação
  • Babiloni C; Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.
  • Arakaki X; San Raffaele of Cassino, Cassino (FR), Italy.
  • Azami H; Huntington Medical Research Institutes, Pasadena, California, USA.
  • Bennys K; Department of Neurology and Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA.
  • Blinowska K; Centre Mémoire de Ressources et de Recherche (CMRR), Centre Hospitalier, Universitaire de Montpellier, Montpellier, France.
  • Bonanni L; Institute of Biocybernetics, Warsaw, Poland.
  • Bujan A; Faculty of Physics University of Warsaw and Nalecz, Warsaw, Poland.
  • Carrillo MC; Department of Neuroscience Imaging and Clinical Sciences and CESI, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy.
  • Cichocki A; Psychological Neuroscience Lab, School of Psychology, University of Minho, Minho, Portugal.
  • de Frutos-Lucas J; Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.
  • Del Percio C; Skolkowo Institute of Science and Technology (SKOLTECH), Moscow, Russia.
  • Dubois B; Systems Research Institute PAS, Warsaw, Poland.
  • Edelmayer R; Nicolaus Copernicus University (UMK), Torun, Poland.
  • Egan G; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
  • Epelbaum S; Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.
  • Escudero J; Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Institute of Memory and Alzheimer's Disease (IM2A), Paris, France.
  • Evans A; ICM, INSERM U1127, CNRS UMR 7225, Sorbonne Université, Institut du Cerveau et de la Moelle épinière, Paris, France.
  • Farina F; Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.
  • Fargo K; Foundation Director of the Monash Biomedical Imaging (MBI) Research Facilities, Monash University, Clayton, Australia.
  • Fernández A; Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Institute of Memory and Alzheimer's Disease (IM2A), Paris, France.
  • Ferri R; ICM, INSERM U1127, CNRS UMR 7225, Sorbonne Université, Institut du Cerveau et de la Moelle épinière, Paris, France.
  • Frisoni G; School of Engineering, Institute for Digital Communications, The University of Edinburgh, Edinburgh, UK.
  • Hampel H; Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
  • Harrington MG; Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
  • Jelic V; Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.
  • Jeong J; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
  • Jiang Y; Oasi Research Institute - IRCCS, Troina, Italy.
  • Kaminski M; IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Kavcic V; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland.
  • Kilborn K; GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, Sorbonne University, Paris, France.
  • Kumar S; Huntington Medical Research Institutes, Pasadena, California, USA.
  • Lam A; Division of Clinical Geriatrics, NVS Department, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Lim L; Department of Bio and Brain Engineering/Program of Brain and Cognitive Engineering Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Lizio R; Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
  • Lopez D; Faculty of Physics University of Warsaw and Nalecz, Warsaw, Poland.
  • Lopez S; Institute of Gerontology, Wayne State University, Detroit, Michigan, USA.
  • Lucey B; School of Psychology, University of Glasgow, Glasgow, UK.
  • Maestú F; Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • McGeown WJ; MGH Epilepsy Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • McKeith I; Vielight Inc., Toronto, Ontario, Canada.
  • Moretti DV; IRCCS SDN, Napoli, Italy.
  • Nobili F; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
  • Noce G; Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.
  • Olichney J; Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Onofrj M; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
  • Osorio R; School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.
  • Parra-Rodriguez M; Newcastle upon Tyne, Translational and Clinical Research Institute, Newcastle University, UK.
  • Rajji T; IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Ritter P; Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy.
  • Soricelli A; Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Alzheimers Dement ; 17(9): 1528-1553, 2021 09.
Article em En | MEDLINE | ID: mdl-33860614
ABSTRACT
The Electrophysiology Professional Interest Area (EPIA) and Global Brain Consortium endorsed recommendations on candidate electroencephalography (EEG) measures for Alzheimer's disease (AD) clinical trials. The Panel reviewed the field literature. As most consistent findings, AD patients with mild cognitive impairment and dementia showed abnormalities in peak frequency, power, and "interrelatedness" at posterior alpha (8-12 Hz) and widespread delta (< 4 Hz) and theta (4-8 Hz) rhythms in relation to disease progression and interventions. The following consensus statements were subscribed (1) Standardization of instructions to patients, resting state EEG (rsEEG) recording methods, and selection of artifact-free rsEEG periods are needed; (2) power density and "interrelatedness" rsEEG measures (e.g., directed transfer function, phase lag index, linear lagged connectivity, etc.) at delta, theta, and alpha frequency bands may be use for stratification of AD patients and monitoring of disease progression and intervention; and (3) international multisectoral initiatives are mandatory for regulatory purposes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Eletroencefalografia / Doença de Alzheimer Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Eletroencefalografia / Doença de Alzheimer Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article